Dopamine agonists in clinical research for new tardive dyskinesia treatments.
D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000008:administration & dosage; D001058:Apomorphine / Q000627:therapeutic use; D001545:Benserazide / Q000008:administration & dosage / Q000627:therapeutic use*; D002230:Carbidopa / Q000627:therapeutic use; D004298:Dopamine / Q000502:physiology; D004338:Drug Combinations / Q000008:administration & dosage / Q000627:therapeutic use; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D007980:Levodopa / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D009435:Synaptic Transmission
D014150:Antipsychotic Agents; D004338:Drug Combinations; D006834:Hydrazines; C005177:benserazide, levodopa drug combination; C009265:carbidopa, levodopa drug combination; D007980:Levodopa; D001545:Benserazide; D002230:Carbidopa; D001058:Apomorphine; D004298:Dopamine